Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ResMed, Inc.
ResMed’s planned buy-out of Germany health care software company Medifox is expected to strengthen its position with out-of-hospital providers outside of the US and strengthen its position as a worldwide leader in health care software solutions.
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights the push behind digital therapeutics, Abbott’s biowearable line, Exec Chats with iRhythm and Cognetivity, Right To Repair rules for tech, and FDA's guidance on 3D-printing.
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the first day of the meeting.
Experts foresee the digital therapeutics market growing to $6bn-$9bn by 2025, driven in part by tech-empowered consumers and patients looking for solutions to better manage their own health and conditions. For medtechs, collaborations with software-driven start-ups will be key to harnessing personalized data and differentiating themselves in the marketplace.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
- Curative Medical, Inc.
- HB Healthcare
- Inova Labs, Inc.
- Jaysec Technologies LLC
- Laboratories Narval
- Maribo Medico
- Propeller Health
- SleepScore Labs, Umbian
- Brightree LLC.